Acciones Isodiol International Inc Other OTC
Acciones
CA46500L1013
Farmacéuticos
Ventas 2018 | 19,14 M 17,63 M | Ventas 2019 | 22,25 M 20,5 M | Capitalización | 49,96 M 46,02 M |
---|---|---|---|---|---|
Resultado Neto 2018 | -36 M -33,16 M | Resultado Neto 2019 | -126 M -116 M | VE / Ventas 2018 | 12,6 x |
Posición de caja neta 2018 | 15,55 M 14,33 M | Deuda neta 2019 | 5,22 M 4,81 M | VE / Ventas 2019 | 2,48 x |
P/E ratio 2018 |
-4,94
x | P/E ratio 2019 |
-0,37
x | Empleados | - |
Rendimiento 2018 * |
-
| Rendimiento 2019 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+42,07 % | 6227,53 M | |
-21,20 % | 4191,87 M | |
+5,38 % | 3320,28 M | |
-16,98 % | 2913,34 M | |
-5,82 % | 2422,07 M | |
+45,47 % | 1937,17 M | |
-12,67 % | 1592,28 M | |
-3,91 % | 1581,2 M | |
+44,56 % | 1491,68 M |